Brentuximab Vedotin effects on prognosis of refractory and relapsed peripheral T-Cell lymphoma: a systematic review. (2019). Revista De Medicina E Saúde De Brasília, 7(2). https://portalrevistas.ucb.br/index.php/rmsbr/article/view/9251